Keywords: تجزیه و تحلیل هزینه و سود; Breast; Cancer; Cost-utility analysis; Mastectomy; Reconstruction; Implant;
مقالات ISI تجزیه و تحلیل هزینه و سود (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تجزیه و تحلیل هزینه و سود; Noninvasive mechanical ventilation; Cost analysis; Acute respiratory failure; Organization; Cost-utility analysis;
Keywords: تجزیه و تحلیل هزینه و سود; cost-utility analysis; orphan services; reciprocity; sharing; social preferences;
Keywords: تجزیه و تحلیل هزینه و سود; automated assessment; cost-effectiveness analysis; cost-utility analysis; depression; direct health care costs; disease management; health technology assessment; primary care; telemedicine;
Keywords: تجزیه و تحلیل هزینه و سود; Cost-utility analysis; Pneumococcal conjugate vaccines; PCV; Human resources for health; Bhutan;
Keywords: تجزیه و تحلیل هزینه و سود; Head and neck cancer; Follow-up; Radiological assessments; Markov model; Cost-utility analysis;
Keywords: تجزیه و تحلیل هزینه و سود; ADPKD; cardiovascular disease; intracranial aneurysms; cost-utility analysis;
Keywords: تجزیه و تحلیل هزینه و سود; bone metastasis; cost-utility analysis; Markov modeling; Monte-Carlo simulation; radiotherapy;
Keywords: تجزیه و تحلیل هزینه و سود; cost-utility analysis; diabetic retinopathy; optometrist; publicly funded eye examination;
Keywords: تجزیه و تحلیل هزینه و سود; cost-utility analysis; preferences; substance use; utility;
Keywords: تجزیه و تحلیل هزینه و سود; Cost-effectiveness analysis; Cost-utility analysis; Economic evaluation; Pancreatic ductal adenocarcinoma; Quality-adjusted life years;
Keywords: تجزیه و تحلیل هزینه و سود; Economic evaluation; cost-utility analysis; cost-effectiveness analysis; diabetic neuropathy; painful diabetic neuropathy; quality of life;
Keywords: تجزیه و تحلیل هزینه و سود; Appendicitis; Nonoperative treatment; Appendectomy; Antibiotics; Cost-utility analysis
Keywords: تجزیه و تحلیل هزینه و سود; cost-effectiveness analysis; cost-benefit analysis; cost-utility analysis; patient's perspective; systematic review;
Keywords: تجزیه و تحلیل هزینه و سود; EE; economic evaluation; OECD; Organization for Economic Co-operation and Development; CEA; cost-effectiveness analysis; CER; cost-effectiveness ratio; ICER; incremental cost-effectiveness ratio; WTP; willingness to pay; NICE; National Institute for Healt
Keywords: تجزیه و تحلیل هزینه و سود; asthma treatment; cost-utility analysis; hospitalization; older adults;
Keywords: تجزیه و تحلیل هزینه و سود; Cervical cancer; cost-utility analysis; human papillomavirus; Indonesia; vaccination;
Keywords: تجزیه و تحلیل هزینه و سود; Economic evaluation; Cost-effectiveness analysis; Cost-benefit analysis; Cost-utility analysis;
Keywords: تجزیه و تحلیل هزینه و سود; Cost-utility analysis; Costs; Economics; Rehabilitation; Spinal cord decompression; Spinal cord injury; Spine surgery; Timing; Trauma; Utility; AIS; American Spinal Injury Association Impairment Scale; ICER; Incremental cost-effectiveness ratio; OMHLTC; O
Keywords: تجزیه و تحلیل هزینه و سود; Vulvar cancer; Sentinel lymph node biopsy; Cost-utility analysis; Lymphedema;
Keywords: تجزیه و تحلیل هزینه و سود; Asia; cost-effectiveness; cost-utility analysis; quality-adjusted life-year;
Keywords: تجزیه و تحلیل هزینه و سود; cost-effectiveness analysis; cost-utility analysis; quality-adjusted life-year; review;
Keywords: تجزیه و تحلیل هزینه و سود; cost-utility analysis; diabetes; health care utilization; systematic review;
Keywords: تجزیه و تحلیل هزینه و سود; cost-effectiveness analysis; cost-utility analysis; end-stage renal disease; high-dose hemodialysis; in-center hemodialysis;
Keywords: تجزیه و تحلیل هزینه و سود; Australia; cost-benefit analysis; cost-utility analysis; DOTS; metapopulation model; PNG; tuberculosis control;
Keywords: تجزیه و تحلیل هزینه و سود; cost-utility analysis; EGFR; first-line; gefitinib; Thailand;
Keywords: تجزیه و تحلیل هزینه و سود; cost-utility analysis; end-stage renal disease; erythropoietin; hemodialysis; Markov model;
Keywords: تجزیه و تحلیل هزینه و سود; Ulipristal acetate; Economic evaluation; Cost-effectiveness; Cost-utility analysis;
Keywords: تجزیه و تحلیل هزینه و سود; axillary lymph node dissection; breast cancer; cost-utility analysis; sentinel lymph node biopsy;
Keywords: تجزیه و تحلیل هزینه و سود; chronic myeloid leukemia; cost-utility analysis; dasatinib; imatinib; leukemia; nilotinib; Thailand;
Keywords: تجزیه و تحلیل هزینه و سود; Advanced colorectal cancer; Metastatic colorectal cancer; Monoclonal antibody; Bevacizumab; Cetuximab; Panitumumab; Targeted therapy; Health economics; Cost-effectiveness analysis; Cost-utility analysis;
Keywords: تجزیه و تحلیل هزینه و سود; Quality of life; Cost-utility analysis; Older people; Long-term care; Review;
Keywords: تجزیه و تحلیل هزینه و سود; cost-utility analysis; genetic testing; Italy; venous thromboembolism;
Keywords: تجزیه و تحلیل هزینه و سود; Dengue; Dengue vaccines; Cost-utility analysis; Argentina
Keywords: تجزیه و تحلیل هزینه و سود; cost-effectiveness analysis; cost-utility analysis; HTA; incremental cost-effectiveness ratio; incremental cost-utility ratio; Poland
Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60â¯years of age or older
Keywords: تجزیه و تحلیل هزینه و سود; Pneumococcal vaccines; 23-valent vaccine; Pneumo-23; Cost-benefit analysis; Economic evaluation; Cost-effectiveness analysis; Cost-utility analysis;
Cost-utility of collaborative nurse-led self-management support for primary care patients with anxiety, depressive or somatic symptoms: A cluster-randomized controlled trial (the SMADS trial)
Keywords: تجزیه و تحلیل هزینه و سود; Anxiety disorders; Collaborative care; Cost-utility analysis; Depressive disorders; Nurses; Primary care; Quality-adjusted life years; Somatoform disorders;
Research paperCost-utility evaluation of vortioxetine in patients with Major Depressive Disorder experiencing inadequate response to alternative antidepressants in the United Kingdom
Keywords: تجزیه و تحلیل هزینه و سود; Major depressive disorder; Depression; Cost-utility analysis; Inadequate response; Vortioxetine;
A cost-utility analysis for catheter ablation of atrial fibrillation in combination with warfarin and dabigatran based on the CHADS2 score in Japan
Keywords: تجزیه و تحلیل هزینه و سود; Cost-utility analysis; Atrial fibrillation; Catheter ablation; Warfarin; Dabigatran;
Value within otolaryngology: Assessment of the cost-utility analysis literature
Keywords: تجزیه و تحلیل هزینه و سود; Cost-utility analysis
Calidad de vida del paciente asmático con beclometasona/formoterol. Análisis de coste-utilidad
Keywords: تجزیه و تحلیل هزینه و سود; Asma; Calidad de vida; Farmacoeconomía; Análisis coste-utilidad; Beclometasona; FormoterolAsthma; Quality of life; Pharmacoeconomics; Cost-utility analysis; Beclomethasone; Formoterol
Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand
Keywords: تجزیه و تحلیل هزینه و سود; HPV vaccination; Cost-effectiveness; Cervical cancer; Anogenital warts; Markov model; Cost-utility analysis; Equity; MÄori health;
A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysis
Keywords: تجزیه و تحلیل هزینه و سود; VeriStrat; Second-line treatment; Non-small cell lung cancer; Cost-utility analysis; Epidermal growth factor receptor inhibitor; Markov model;
Keywords: تجزیه و تحلیل هزینه و سود; cost-utility analysis; EQ-5D; health-related quality of life; quality-adjusted life years; time trade-off
Keywords: تجزیه و تحلیل هزینه و سود; cost-effectiveness analysis; cost-utility analysis; Nigeria; patients with type 2 diabetes; pharmaceutical care; usual care
Keywords: تجزیه و تحلیل هزینه و سود; chronic low back pain; cost-effectiveness; cost-utility analysis; duloxetine; pharmacoeconomic model
Keywords: تجزیه و تحلیل هزینه و سود; cost-effectiveness analysis; cost-utility analysis; disease progression; health-related quality of life; osteoarthritis
Keywords: تجزیه و تحلیل هزینه و سود; depression; diabetes-related complications; direct care health costs; cost-utility analysis; randomized clinical trial
Keywords: تجزیه و تحلیل هزینه و سود; anastrozole; breast cancer; cost-effectiveness analysis; cost-utility analysis; tamoxifen
Keywords: تجزیه و تحلیل هزینه و سود; cost-utility analysis; decision analysis model; postmenopausal osteoporosis; screening; treatment